Papers
2
Total Citations
58
H-Index
2
About
Dr. Sinae Kim is a clinical researcher whose work focuses on refining risk stratification and surgical management in prostate cancer, particularly for low-risk patients. Her most cited study, "Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer" (2015, 50 citations), introduced a novel, accessible biomarker approach using routine blood counts to better identify which low-risk patients might harbor more aggressive disease, potentially reducing overtreatment. She further investigated treatment patterns in "Utilization of Pelvic Lymph Node Dissection for Patients With Low-Risk Prostate Cancer Treated With Robot-Assisted Radical Prostatectomy" (2017, 8 citations), examining real-world surgical decision-making. By integrating simple, cost-effective markers into clinical algorithms, Dr. Kim’s work contributes to more personalized, evidence-based care for men with prostate cancer, helping to balance the risks of unnecessary intervention against the need for timely treatment. Her research underscores the value of leveraging existing clinical data to improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2